SCHEMBL25829889

SCHEMBL25829889

COC(=O)CC(Cc1ccccc1)S(N)(=O)=N[Si](C)(C)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MMP1 P03956 2/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ AGTR1 P30556 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25829887 0.86 ALDH1A1 (0.41) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL21962930 0.79 MEN1 (0.53) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL25014618 0.78 MMP1 (0.41) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL21962906 0.77 MMP1 (0.49) MEN1KMT2AMMP1MMP2MMP3
SCHEMBL22010524 0.77 KMT2A (0.46) MEN1KMT2ACA9CA2POLB
SCHEMBL22010629 0.71 F2 (0.41) CA9CA2POLBCA12CA1
SCHEMBL22280141 0.69 BLM (0.41) ALDH1A1TSHRCA9CA2CYP2C19
SCHEMBL25014622 0.69 MMP1 (0.40) MEN1KMT2AMMP1ALDH1A1LMNA
SCHEMBL9554305 0.69 ITGA4 (0.51) ALDH1A1LMNAPKMHPGDTSHR
SCHEMBL26954314 0.68 MMP1 (0.52) MMP1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3880666-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-06-28 — — EP disclosed
Send feedback